CCAL
KNSA icon

City Center Advisors LLC’s Kiniksa Pharmaceuticals KNSA Stock Holding History

City Center Advisors LLC’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$393K Buy
+5,271
New +$388K 0.3% 95

Other funds holding KNSA

TFA
Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return
JWS
Juncture Wealth Strategies Scottsdale, Arizona $390M AUM 19.15% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

City Center Advisors LLC's KNSA Position: Q3 2026 in Review

City Center Advisors LLC opened a new position in Kiniksa Pharmaceuticals (KNSA) in Q3 2026: 5,271 shares worth $393K. The stake represents 0.3% of the portfolio and ranks #95 among its holdings.

8 funds tracked by Wall St. Rank hold KNSA as of Q3 2026.

  • City Center Advisors LLC held 5,271 shares of Kiniksa Pharmaceuticals worth $393K as of Q3 2026.
  • Kiniksa Pharmaceuticals was a new City Center Advisors LLC position in Q3 2026.
  • Kiniksa Pharmaceuticals made up 0.3% of City Center Advisors LLC's portfolio in Q3 2026, its #95 holding.
  • 8 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q3 2026.

Based on City Center Advisors LLC's 13F filing for Q3 2026, filed 8 Oct 2026.